| Full Name | Joni Smart |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4538 Us Hwy 231, Wetumpka, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538699129 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14851 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joni Smart, 4538 Us Highway 231, Wetumpka, AL 36092-3333 Ph: (334) 567-3077 | Joni Smart, 4538 Us Hwy 231, Wetumpka, AL 36092 Ph: (334) 567-3077 |
News Archive
Today at the 21st annual meeting of the IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicines in Paris, France, Roche unveiled a series of new diagnostic technologies.
New research on the genomics of autism confirms that the genetic roots of the disorder are highly complicated, but that common biological themes underlie this complexity. In the current study, researchers have implicated several new candidate genes and genomic variants as contributors to autism, and conclude that many more remain to be discovered.
Rep. Barbara Lee (D-Calif.) and Sens. Chris Coons (D-Del.), Marco Rubio (R-Fla.) and Mike Enzi (R-Wyo.) on Wednesday at the XIX International AIDS Conference in Washington, D.C., joined former Senate Majority Leader Bill Frist (R-Tenn.) for a panel discussion on bipartisanship "focusing on sustaining the engagement of the U.S. Congress in order to demonstrate and encourage continued U.S. leadership in the fight against global AIDS," the Center for Global Health Policy's "Science Speaks" blog reports.
Stand Up To Cancer, the charitable initiative supporting ground-breaking research aimed at getting new cancer treatments to patients in an accelerated timeframe, announces that Jeffrey A. Sosman, M.D., a Stand Up To Cancer Melanoma Dream Team investigator, William Pao, M.D., Ph.D., a 2009 Stand Up To Cancer Innovative Research Grant recipient and colleagues identified two novel BRAF fusions in melanomas previously considered to be negative for molecular targets, and that melanomas with these fusions were found to be potentially sensitive to anticancer drugs called MEK inhibitors, according to a study recently published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.
› Verified 1 days ago
Dr. Frank T Mitchell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4538 Us Highway 231, Wetumpka, AL 36092 Phone: 334-567-3077 | |
Mr. Gregory Eudell Crane, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 806 Company St, Wetumpka, AL 36092 Phone: 334-201-8547 | |
Mrs. Stephanie Brown Seale, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 795 Wilson St, Wetumpka, AL 36092 Phone: 334-514-7135 Fax: 334-514-2257 | |
Dr. Kimberly Moses, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 795 Wilson St, Wetumpka, AL 36092 Phone: 334-514-7135 | |
Mr. Carl Bledsoe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5268 Us Highway 231, Wetumpka, AL 36092 Phone: 334-567-5136 Fax: 334-567-5142 | |
Jennifer Nagel Muffley, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5326 Us Highway 231, Wetumpka, AL 36092 Phone: 334-567-2420 Fax: 334-567-0906 | |
Dr. Tanvi Singh, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 763 Wilson St, Wetumpka, AL 36092 Phone: 334-567-2083 |